✦ LIBER ✦

Use of rituximab in Hispanic patients with severe ANCA associated vasculitis: A 6 years experience in a tertiary centre in Chile

✍ Scribed by Silva, F.; Massardo, L.; Mimica, M.; Pastenes, P.; Cisternas, M.; Radrigan, F.; Gutierrez, M.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical characteristics of ANCA associa

✍ Cisternas, M.; Lira, M.J.; Silva, F. 📂 Article 📅 2013 🏛 Masson Editeur 🌐 French ⚖ 65 KB

Re-treatment with rituximab in ANCA-asso

✍ Jeannin, G.; Salviani, C.; Possenti, S.; Regazzoli, A.; Allegri, F.; Cancarini, 📂 Article 📅 2013 🏛 Masson Editeur 🌐 French ⚖ 70 KB

Classification of clinical subtypes, pat

✍ Kimimasa Nakabayashi; Yoshihiro Arimura; Ken Yoshihara; Toshihiro Fukuoka; Miho 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 227 KB

PO.39 EFFICACY AND SAFETY OF ADALIMUMAB

✍ M.L. Scribano; A. Kohn; P. Meddi; L.A. Giglio; C. Prantera 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 76 KB

Use of Whole-Blood Transcriptomic Profil

✍ Sellam, Jérémie; Marion-Thore, Sandrine; Dumont, Florent; Jacques, Sébastien; Ga 📂 Article 📅 2014 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 853 KB

A 5 years parallel observation study of

✍ N. Hamada; E. Soylu; A. Fahy; W. Tawfick; S. Sultan 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 67 KB